Paul Yeh1, William G Ondo2, Daniel L Picchietti3, J Steven Poceta4, Richard P Allen5, Charles R Davies3, Lily Wang6, Yaping Shi6, Kanika Bagai7, Arthur S Walters7. 1. Department of Psychiatry, University of Texas Health Science Center at San Antonio, TX. 2. Department of Neurology, Methodist Neurological Institute, Houston, TX. 3. Carle Neuroscience Institute, University of Illinois College of Medicine at Urbana-Champaign, Urbana, IL. 4. Viterbi Family Sleep Center, Scripps Clinic, La Jolla, CA. 5. RLS Center, Johns Hopkins University School of Medicine, Baltimore, MD. 6. Department of Biostatistics, Vanderbilt School of Medicine, Nashville, TN. 7. Department of Neurology, Vanderbilt University Medical Center, Nashville, TN.
Abstract
STUDY OBJECTIVES: To determine the depth and distribution of sensory discomfort in idiopathic restless legs syndrome/Willis-Ekbom disease (RLS) and RLS concurrent with other leg conditions, specifically peripheral neuropathy, sciatica, leg cramps, and arthritis. METHODS: RLS subjects (n = 122) were divided into 71 idiopathic RLS and 51 RLS-C, or Comorbid, groups. All subjects were examined by an RLS expert, answered standardized RLS questionnaires, and received a body diagram to draw the location and depth of their symptoms. RESULTS: Age was 63.04 ± 12.84 years, with 77 females and 45 males. All patients had lower limb involvement and 43/122 (35.25%) also had upper limb involvement. Of the 122 subjects, 42.62% felt that the RLS discomfort was only deep, 9.84% felt that the discomfort was only superficial, and 47.54% felt both superficial and deep discomfort. There were no defining characteristics in depth or distribution of RLS sensations that differentiated those patients with idiopathic RLS from those patients with RLS associated with other comorbid leg conditions. The sensation of arthritis was felt almost exclusively in the joints and not in the four quadrants of the leg, whereas the exact opposite was true of RLS sensations. CONCLUSIONS: Depth and distribution cannot be used as a discriminative mechanism to separate out idiopathic RLS from RLS comorbid with other leg conditions. Although seen in clinical practice, the total absence of patients with non-painful RLS only in the joints in the current study attests to the rarity of this presentation and raises the possibility of misdiagnosis under these circumstances. We recommend that such patients not be admitted to genetic or epidemiological studies.
STUDY OBJECTIVES: To determine the depth and distribution of sensory discomfort in idiopathic restless legs syndrome/Willis-Ekbom disease (RLS) and RLS concurrent with other leg conditions, specifically peripheral neuropathy, sciatica, leg cramps, and arthritis. METHODS:RLS subjects (n = 122) were divided into 71 idiopathic RLS and 51 RLS-C, or Comorbid, groups. All subjects were examined by an RLS expert, answered standardized RLS questionnaires, and received a body diagram to draw the location and depth of their symptoms. RESULTS: Age was 63.04 ± 12.84 years, with 77 females and 45 males. All patients had lower limb involvement and 43/122 (35.25%) also had upper limb involvement. Of the 122 subjects, 42.62% felt that the RLS discomfort was only deep, 9.84% felt that the discomfort was only superficial, and 47.54% felt both superficial and deep discomfort. There were no defining characteristics in depth or distribution of RLS sensations that differentiated those patients with idiopathic RLS from those patients with RLS associated with other comorbid leg conditions. The sensation of arthritis was felt almost exclusively in the joints and not in the four quadrants of the leg, whereas the exact opposite was true of RLS sensations. CONCLUSIONS: Depth and distribution cannot be used as a discriminative mechanism to separate out idiopathic RLS from RLS comorbid with other leg conditions. Although seen in clinical practice, the total absence of patients with non-painful RLS only in the joints in the current study attests to the rarity of this presentation and raises the possibility of misdiagnosis under these circumstances. We recommend that such patients not be admitted to genetic or epidemiological studies.
Authors: S Whittom; Y Dauvilliers; M-H Pennestri; F Vercauteren; N Molinari; D Petit; J Montplaisir Journal: Sleep Med Date: 2007-07-17 Impact factor: 3.492
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee Journal: Sleep Med Date: 2014-05-17 Impact factor: 3.492
Authors: Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li Journal: Exp Neurol Date: 2019-11-09 Impact factor: 5.330
Authors: Ana Carolina Sierra Montoya; Sandra Catalina Mesa Restrepo; Jorge Mauricio Cuartas Arias; William Cornejo Ochoa Journal: Int J Psychol Res (Medellin) Date: 2018 Jan-Jun